3 rezultatus
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a .sctn. 371 national stage entry of International Application No. PCT/KR2015/003340, filed on Apr. 3, 2015, which claims priority to South Korean Patent Application No. 10-2014-0044150, filed on Apr. 14, 2014, and South Korean Patent
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 3, 2017, is named P12589-05_ST25.txt and
BACKGROUND OF THE INVENTION
Development of safe and effective agents for reducing the risk of cancer and other chronic diseases is a high priority of contemporary medicine. Implementation of strategies for chemoprevention/chemoprotection is beset with many problems.
In the economically developed